AstraZeneca’s Lynparza shows significant PFS benefit in ovarian cancer patients - (Pharma) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, October 26, 2016

AstraZeneca’s Lynparza shows significant PFS benefit in ovarian cancer patients - (Pharma)



Pharmaceutical Business Review

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.